EU drug regulator: Uncommon blood clot is ‘very uncommon AstraZeneca aspect impact’

At a press briefing, EMA government director Emer Cooke stated that the mix of blood clots and low blood platelets was very uncommon however was seen in “all ages, and in women and men”, and there was no obtainable proof of “particular danger components resembling age, gender, or earlier medical historical past of clotting issues”.

Source link

Please follow and like us:

Leave a Reply

Your email address will not be published. Required fields are marked *